Cruxi research & evidence
Cosmetic Contract Manufacturers & Private Label evidence guides — page 38
Compare documented facts, dated analyses and evidence that can change your project scope. Confirm applicability with a specialist.
Compare Cosmetic Contract Manufacturers & Private Label providers- Warfarin (INN) and its salts: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- Waste solids, coal-tar pitch coking, if they contain > 0.005 % w/w benzo[a]pyrene: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- Water-soluble zinc salts with the exception of zinc 4- hydroxy-benzene sulphonate (entry 25 of Annex III): EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- Yohimbine and its salts: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- ZINC ACETATE: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- ZINC CHLORIDE: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- ZINC CITRATE: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- ZINC GLUTAMATE: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- ZINC SULFATE: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- Zirconium and its compounds, with the exception of the substances listed under reference number 50 in Annex III, and the zirconium lakes, pigments or salts of the colouring agents when listed Annex IV: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- [1R-(1alpha)]-alpha- Ethenyldecahydro- 2-hydroxy-a,2,5,5,8a- pentamethyl- 1-naphthalenepropanol: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- [3R-(3α,3aβ,7β,8aα)]- 1-(2,3,4,7,8,8a- hexahydro-3,6,8,8-tetramethyl- 1H-3a,7-methanoazulen-5-yl)ethan- 1-one: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- [4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid (Tiratricol (INN)) and its salts: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- [6-[[3-Chloro-4-(methylamino)phenyl]imino]-4-methyl-3-oxocyclohexa-1,4-dien-1-yl]urea (HC Red No 9) and its salts, when used as a substance in hair dye products: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- alpha-(2-Oxoborn-3-ylidene)toluene-4-sulphonic acid and its salts: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- alpha-Piperidin-2-ylbenzyl acetate, laevorotatory threoform (levofacetoperane (INN)) and its salts: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- beta Carotene: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- bis(8-hydroxyquinolinium) sulphate: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- gamma-Terpinene; p-Mentha-1,4-diene: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- m-Phenylenediamine and its salts: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- m-Phenylenediamine, 4-(phenylazo)-, and its salts, when used as a substance in hair dye products: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- o-Hydroxy- benzaldehyde: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- p-Mentha-1,3-diene: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- p-Mentha-1,8-dien-7-al: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
- p-methylhydrocinnamic aldehyde; Cresylpropionaldehyde; p-Methyldihydrocinnamaldehyde: EU cosmetic annex conditions and formula evidenceIngredient legal-condition analysis
Page 38 of 39